Chrysin Ameliorates Hepatic Steatosis Induced by a Diet Deficient in Methionine and Choline by Inducing the Secretion of Hepatocyte Nuclear Factor 4α-dependent Very Low-density Lipoprotein
Overview
Molecular Biology
Toxicology
Affiliations
We investigated the effects of chrysin (CHR) on nonalcoholic fatty liver disease (NAFLD) in mice. The NAFLD mouse model was established using a diet deficient in methionine and choline (MCD). CHR was shown to attenuate MCD-induced hepatic fat accumulation, increase very low-density lipoprotein (VLDL) secretion, and decrease hepatic oxidative stress in NAFLD mice. Inhibition of oxidative stress or direct suppression of protein kinase C (PKC) by CHR significantly reduced PKC activity in the liver, leading to a decrease in inhibitory phosphorylation of hepatocyte nuclear factor 4α (HNF4α). The resulting activation of HNF4α led to induced transcription of apolipoprotein B and VLDL secretion. Together, these results show that CHR effectively ameliorates MCD-induced fatty liver in NAFLD mice by targeting the hepatic oxidative stress/PKC/HNF4α signaling pathway.
Anticancer Activity of Ether Derivatives of Chrysin.
Sokal A, Mruczek P, Niedoba M, Dewalska A, Stocerz K, Kadela-Tomanek M Molecules. 2025; 30(4).
PMID: 40005270 PMC: 11857933. DOI: 10.3390/molecules30040960.
Zhang R, Gao C, Hu M, Wang X, Li S, An Z Front Pharmacol. 2024; 15:1336232.
PMID: 38708081 PMC: 11066169. DOI: 10.3389/fphar.2024.1336232.
Fu Y, Wang Z, Qin H Metabolites. 2024; 14(4).
PMID: 38668346 PMC: 11052500. DOI: 10.3390/metabo14040218.
Zorzi G, Gambini S, Negri S, Guzzo F, Commisso M Plants (Basel). 2023; 12(3).
PMID: 36771739 PMC: 9920315. DOI: 10.3390/plants12030655.
Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent.
Stompor-Goracy M, Bajek-Bil A, Machaczka M Nutrients. 2021; 13(6).
PMID: 34198618 PMC: 8232110. DOI: 10.3390/nu13062038.